Lion Point Capital »

Mineralys Therapeutics shares owned by Lion Point Capital

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $924k 79k 11.70
2024-03-31 $775k 60k 12.91

More positions owned by Lion Point Capital

Ishares Tr Russell 2000 Etf Put Option (IWM)
Ardelyx (ARDX)
Insmed Com Par $.01 (INSM)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Milestone Pharmaceuticals (MIST)
Geron Corporation (GERN)
Marinus Pharmaceuticals Com New (MRNS)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Mirum Pharmaceuticals Put Option (MIRM)
Syndax Pharmaceuticals (SNDX)
Bridgebio Pharma (BBIO)
Avadel Pharmaceuticals Com Shs (AVDL)
Neurocrine Biosciences (NBIX)
Fennec Pharmaceuticals (FENC)
Mineralys Therapeutics (MLYS)

View all positions for Lion Point Capital

Top funds holding Mineralys Therapeutics

Catalys Pacific
Samsara BioCapital
RA Capital Management
TCG Crossover Management
BlackRock
OrbiMed Advisors
Sr One Capital Management
Franklin Resources
Laurion Capital Management
Vanguard Group
Caligan Partners
American Century Companies
Jennison Associates
Octagon Capital Advisors
Geode Capital Management

View all funds holding Mineralys Therapeutics